Gene · 282618
Papers3,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease. | N Engl J Med | 2024 | 39083772 | PubTator, text mining | PubMed |
| Evolutionary insights of interferon lambda genes in tetrapods. | J Evol Biol | 2024 | 39066611 | PubTator, text mining | PubMed |
| Mucosal IFNλ1 mRNA-based immunomodulation effectively reduces SARS-CoV-2 induced mortality in mice. | EMBO Rep | 2024 | 39060455 | PubTator, text mining | PubMed |
| Unconventional posttranslational modification in innate immunity. | Cell Mol Life Sci | 2024 | 38970666 | PubTator, text mining | PubMed |
| Non-infectious immune complexes downregulate the production of interferons and tumor necrosis factor-α in primary porcine alveolar macrophages in vitro. | Front Vet Sci | 2024 | 38962699 | PubTator, text mining | PubMed |
| IL-10 predicts incident neuroinflammatory disease and proviral load dynamics in a large Brazilian cohort of people living with human T-lymphotropic virus type 1. | Front Immunol | 2024 | 38962007 | PubTator, text mining | PubMed |
| Reduced IFNL1 and/or IFNL2, but not IFNL3 is associated with worse outcome in patients with COVID-19. | Clin Exp Immunol | 2024 | 38953458 | PubTator, text mining | PubMed |
| The Identification and Function of Linc01615 on Influenza Virus Infection and Antiviral Response. | Int J Mol Sci | 2024 | 38928290 | PubTator, text mining | PubMed |
| Effect of sitagliptin therapy on IL-29 and its associated signaling molecules in patients with type 2 diabetes mellitus. | Hum Immunol | 2024 | 38897073 | PubTator, text mining | PubMed |
| ATG10S promotes IFNL1 expression and autophagic degradation of multiple viral proteins mediated by IFNL1. | Autophagy | 2024 | 38842055 | PubTator, text mining | PubMed |
| Human Alveolar and Monocyte-Derived Human Macrophage Responses to Mycobacterium tuberculosis. | J Immunol | 2024 | 38836816 | PubTator, text mining | PubMed |
| C5a peptidase (ScpA) activity towards human type II and type III interferons. | Cytokine | 2024 | 38759527 | PubTator, text mining | PubMed |
| Decidual production of interferon lambda in response to ZIKV persistence: Clinical evidence and in vitro modelling. | Heliyon | 2024 | 38737240 | PubTator, text mining | PubMed |
| Characterization and expression profiling of buffalo IFN-lambda family. | Vet Immunol Immunopathol | 2024 | 38735115 | PubTator, text mining | PubMed |
| Coinfection with respiratory syncytial virus and rhinovirus increases IFN-λ1 and CXCL10 expression in human primary bronchial epithelial cells. | New Microbiol | 2024 | 38700885 | PubTator, text mining | PubMed |
| Grainyhead-like-2, an epithelial master programmer, promotes interferon induction and suppresses breast cancer recurrence. | Mol Immunol | 2024 | 38692097 | PubTator, text mining | PubMed |
| Search for cerebrospinal fluid biomarkers in patients with major psychiatric disorders: Multiplex immunoassay findings and proximity extension assay prospects. | Neuropsychopharmacol Rep | 2024 | 38686540 | PubTator, text mining | PubMed |
| Oral Antiviral Defense: Saliva- and Beverage-like Hypotonicity Dynamically Regulate Formation of Membraneless Biomolecular Condensates of Antiviral Human MxA in Oral Epithelial Cells. | Cells | 2024 | 38607029 | PubTator, text mining | PubMed |
| Swine acute diarrhea syndrome coronavirus Nsp1 suppresses IFN-λ1 production by degrading IRF1 via ubiquitin-proteasome pathway. | Vet Res | 2024 | 38589958 | PubTator, text mining | PubMed |
| Changes in the innate immune response to SARS-CoV-2 with advancing age in humans. | Immun Ageing | 2024 | 38515147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/282618/papers?page=7